As shown in Figures 1B, 1C, and 1D, compared with benign lung disease patients, the Hsp90α level was significantly higher in squamous cell carcinoma, adenocarcinoma, and small-cell lung cancer. This evidence concerns the gene HSP90AA1 and squamous cell carcinoma.